Mirae Asset Global Investments’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
SCM
ACM
Mirae Asset Global Investments's KURA Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Kura Oncology (KURA) stake by 13% in Q2 2026, selling an estimated $5.37K and leaving 3,970 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.
Mirae Asset Global Investments first reported a position in KURA in Q2 2022 and has held it in 17 quarters since. The position peaked at $611K in Q1 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- Mirae Asset Global Investments held 3,970 shares of Kura Oncology worth $43.6K as of Q2 2026.
- Mirae Asset Global Investments sold 569 Kura Oncology shares in Q2 2026, an estimated $5.37K.
- Kura Oncology made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1374 holding.
- Mirae Asset Global Investments first reported a position in Kura Oncology in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Kura Oncology position peaked at $611K in Q1 2024.
- 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.